Cubist Systematic Strategies, LLC Sutro Biopharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $517,447 - $944,518	-177,208 Reduced 91.5%	16,463 $48,000
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $384,372 - $664,129	117,545 Added 154.41%	193,671 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $157,580 - $345,612	76,126 New	76,126 $326,000
Q2 2023 Aug 14, 2023	SELL	$4.25 - $5.88 $494,330 - $683,920	-116,313 Reduced 87.57%	16,517 $76,000
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $212,531 - $400,867	47,440 Added 55.56%	132,830 $613,000
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $1.4 Million - $2.08 Million	-257,994 Reduced 75.13%	85,390 $689,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $480,784 - $661,194	92,995 Added 37.14%	343,384 $1.91 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $562,032 - $1.48 Million	164,819 Added 192.61%	250,389 $1.31 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $665,734 - $1.31 Million	85,570 New	85,570 $703,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $78,560 - $129,720	-5,513 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $388,020 - $514,449	-22,987 Reduced 80.66%	5,513 $104,000
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $192,199 - $253,921	-10,660 Reduced 27.22%	28,500 $530,000
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $459,832 - $624,139	22,663 Added 137.38%	39,160 $891,000
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $63,682 - $150,306	6,268 Added 61.28%	16,497 $358,000
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $72,130 - $127,489	9,695 Added 1815.54%	10,229 $103,000
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $3,866 - $5,900	534 New	534 $4,000
Q3 2019 Nov 14, 2019	SELL	$7.91 - $11.76 $7,609 - $11,313	-962 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.69 - $12.23 $9,321 - $11,765	962 New	962 $11,000

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

Suvretta Capital Management, LLC New York, NY

7.19M
Shares

$13.5 Million
0.98% of portfolio
Black Rock Inc. New York, NY

6.91M
Shares

$13 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.2M
Shares

$7.89 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3M
Shares

$5.64 Million
0.03% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.83M
Shares

$5.32 Million
1.53% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account